Venetoclax-based lower-intensity regimens for acute myeloid leukemia: Clinical pearls for a new standard of care. Can Hematol Today [Internet]. 2023 Mar. 1 [cited 2026 Aug. 22];2(1):23–27. Available from: https://canadianhematologytoday.com/article/view/2-1-5-richard-carpentier